Journal article
Tirofiban Protocol Protects Against Delayed Cerebral Ischemia: A Case-Series Study
Neurosurgery, Vol.87(5), pp.E552-E556
10/15/2020
DOI: 10.1093/neuros/nyaa170
PMID: 32415850
Abstract
There has not been any effective prophylaxis for delayed cerebral ischemia delayed cerebral ischemia (DCI) since the introduction of nimodipine. Platelet inhibition may reduce the risk by preventing the formation of microthrombi. Tirofiban has been used as a single monotherapy bridge given its safety profile and controlled platelet inhibition.
To assess the risk of DCI in aneurysmal subarachnoid hemorrhages (aSAH) patients treated with the tirofiban protocol.
aSAH patients between December 2010 and March 2019 who were treated with stent assisted coiling or flow-diverting device were started on a continuous tirofiban infusion protocol and were compared with patients who underwent coil embolization without antiplatelet therapy. Safety analysis was performed to assess DCI, hemorrhagic, and ischemic events.
A total of 21 patients were included in the tirofiban series and 81 in the control group. There was no statistical difference in age, gender, Hunt-Hess grade, and Fisher scale between the 2 groups except for a higher Fisher grade II in the tirofiban group. Multivariate analysis revealed tirofiban to reduce the risk of vasospasm by 72 percent (OR .28, P = .03), without affecting the risk of hemorrhagic complications (OR = 0.50, P = .26). Tirofiban reduced the risk of symptomatic stroke endovascular procedure but it did not reach significance (P = .06). DCI, older age, and postprocedural symptomatic stroke were significant predictors of mortality. Tirofiban reduced the mortality risk, but this association was not statistically significant.
The tirofiban protocol in aSAH patients reduces the risk of DCI without conferring additional risks. This supports previous findings were antiplatelet therapy reduced DCI in human and animal models.
Details
- Title: Subtitle
- Tirofiban Protocol Protects Against Delayed Cerebral Ischemia: A Case-Series Study
- Creators
- Mario Zanaty - Department of Neurosurgery, University of Iowa Hospitals and Clinics, Iowa City, IowaCarlos Osorno-Cruz - Department of Neurosurgery, University of Iowa Hospitals and Clinics, Iowa City, IowaStefano Byer - Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IowaJorge A Roa - Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IowaKaustubh Limaye - Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IowaDaizo Ishii - Department of Neurosurgery, University of Iowa Hospitals and Clinics, Iowa City, IowaDaichi Nakagawa - Department of Neurosurgery, University of Tokyo, Tokyo, JapanJames Torner - Department of Epidemiology, University of Iowa Hospitals and Clinics, Iowa City, IowaLu Yongjun - Department of Neurosurgery, University of Iowa Hospitals and Clinics, Iowa City, IowaSantiago Ortega-Gutiérrez - Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IowaEdgar A Samaniego - Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IowaLauren Allan - Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, IowaDavid Hasan - Department of Neurosurgery, University of Tokyo, Tokyo, Japan
- Resource Type
- Journal article
- Publication Details
- Neurosurgery, Vol.87(5), pp.E552-E556
- DOI
- 10.1093/neuros/nyaa170
- PMID
- 32415850
- NLM abbreviation
- Neurosurgery
- ISSN
- 0148-396X
- eISSN
- 1524-4040
- Publisher
- United States
- Language
- English
- Date published
- 10/15/2020
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Neurology; Radiology; Critical Care; Stead Family Department of Pediatrics; Epidemiology; Iowa Neuroscience Institute; Surgery; Injury Prevention Research Center; Neurosurgery; Otolaryngology
- Record Identifier
- 9984070521102771
Metrics
37 Record Views